Methylation of the γ-Catenin Gene Is Associated With Poor Prognosis of Renal Cell Carcinoma

Clinical Cancer Research

Volumn 11, Issue 2, 2005, Pages 557-564

  Breault, Julia E ^a   Shiina, Hiroaki ^a   Igawa, Mikio ^b   Ribeiro filho, Leopoldo A ^a   Deguchi, Masao ^a   Enokida, Hideki ^a   Urakami, Shinji ^a   Terashima, Masaharu ^b   Nakagawa, Masayuki ^c   Kane, Christopher J ^a   Carroll, Peter ^a   Dahiya, Rajvir ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SHIMANE UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GENOMIC DNA; MESSENGER RNA; PLAKOGLOBIN; RNA;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER SURVIVAL; CELL POPULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DISEASE COURSE; DNA EXTRACTION; DNA METHYLATION; DNA SEQUENCE; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; AZACITIDINE; CARCINOMA, RENAL CELL; CPG ISLANDS; CYTOSKELETAL PROTEINS; DESMOPLAKINS; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; ENZYME INHIBITORS; FEMALE; GAMMA CATENIN; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; PROMOTER REGIONS (GENETICS); SURVIVAL RATE;

EID: 19944428261     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451–5.
2. Aberle H, Bierkamp C, Torchard D, et al. The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc Natl Acad Sci U S A 1995;92:6384–8.
3. McCrea PD, Turck CW, Gumbiner B. A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. Science 1991;254:1359–61.
4. Tselepis C, Chidgey M, North A, Garrod D. Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci U S A 1998;95:8064–9.
5. Butz S, Stappert J, Weissig H, Kemler R. Plakoglobin and γ-catenin: distinct but closely related. Science 1992;257:1142–4.
6. Syrigos KN, Harrington K, Waxman J, Krausz T, Pignatelli M. Altered g-catenin expression correlates with poor survival in patients with bladder cancer. J Urol 1998;160:1889–93.
7. Shimazui T, Schalken JA, Giroldi LA, et al. Prognostic value of cadherin-associated molecules (α-, β-, and γ-catenins and p120cas) in bladder tumors. Cancer Res 1996;56:4154–8.
8. McLaughlin JK, Lipworth L. Epidemiologic aspects of renal cell cancer. Semin Oncol 2000;27:115–23.
9. Porena M, Vespasiani G, Rosi P, et al. Incidentally detected renal cell carcinoma: role of ultrasonography. J Clin Ultrasound 1992;20:395–400.
10. Lerner SE, Hawkins CA, Blute ML, et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 1996;155:1868–73.
11. Chow GK, Myles J, Novick AC. The Cleveland Clinic experience with papillary (chromophil) renal cell carcinoma: clinical outcome with histopathological correlation. Can J Urol 2001;8:1223–8.
12. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003;30:843–852.
13. Flavell RB. Inactivation of gene expression in plants as a consequence of specific sequence duplication. Proc Natl Acad Sci U S A 1994;91:3490–6.
14. Bender CM, Pao MM, Jones PA. Inhibition of DNA methylation by 5-aza-2V-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 1998;58:95–101.
15. Cerrato A, Fulciniti F, Avallone A, Benincasa G, Palombini L, Grieco M. β- and γ-catenin expression in thyroid carcinomas. J Pathol 1998;185:267–72.
16. Pantel K, Passlick B, Vogt J, et al. Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer. J Clin Oncol 1998;16:1407–13.
17. Winn RA, Bremnes RM, Bemis L, et al. γ-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 2002;21:7497–506.
18. Guinan P, Sobin LH, Algaba F, et al. TNM staging of renal cell carcinoma: Workgroup No. 3. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:992–3.
19. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969;101:297–301.
20. Sasaki M, Anast J, Bassett W, Kawakami T, Sakuragi N, Dahiya R. Bisulfite conversion-specific and methylation-specific PCR: a sensitive technique for accurate evaluation of CpG methylation. Biochem Biophys Res Commun 2003;309:305–9.
21. Potter E, Braun S, Lehmann U, Brabant G. Molecular cloning of a functional promoter of the human plakoglobin gene. Eur J Endocrinol 2001;145:625–33.
22. Li LC, Zhao H, Nakajima K, et al. Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J Urol 2001;166:705–9.
23. Shiina H, Igawa M, Shigeno K, et al. γ-catenin mutations correlate with over expression of C-myc and cyclin D1 genes in bladder cancer. J Urol 2002;168:2220–6.
24. Buchner A, Oberneder R, Riesenberg R, Keiditsch E, Hofstetter A. Expression of plakoglobin in renal cell carcinoma. Anticancer Res 1998;18:4231–5.
25. Nojima D, Nakajima K, Li LC, et al. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma. Mol Carcinog 2001;32:19–27.
26. Simcha I, Geiger B, Yehuda-Levenberg S, Salomon, Ben-Ze'ev A. Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin. J Cell Biol 1996;133:199–209.
27. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998;58:1130–4.
28. Kodama S, Ikeda S, Asahara T, Kishida M, Kikuchi A. Axin directly interacts with plakoglobin and regulates its stability. J Biol Chem 1999;274:27682–8.